RenovoRx, Inc. financial data

Symbol
RNXT on Nasdaq
Location
333 W. Santa Clara Street, Suite 900, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 87.2 % -16.2%
Return On Equity -243 % +29.7%
Return On Assets -130 % +23.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24M shares +124%
Common Stock, Shares, Outstanding 24M shares +124%
Entity Public Float 15.5M USD 0%
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 24.9M shares +133%
Weighted Average Number of Shares Outstanding, Diluted 24.9M shares +133%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.22M USD -7.83%
General and Administrative Expense 4.89M USD -20.1%
Operating Income (Loss) -10.1M USD +14.2%
Nonoperating Income (Expense) 952K USD -63.8%
Net Income (Loss) Attributable to Parent -9.16M USD -0.02%
Earnings Per Share, Basic -0.55 USD/shares +41.5%
Earnings Per Share, Diluted -0.55 USD/shares +23.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.56M USD +196%
Marketable Securities, Current 2.05M USD
Cash, Cash Equivalents, and Short-term Investments 6.4M USD
Assets, Current 7.27M USD -55.4%
Assets 10M USD +185%
Accounts Payable, Current 686K USD +96%
Accrued Liabilities, Current 1.09M USD -13.5%
Liabilities, Current 1.77M USD +10.4%
Liabilities 2.96M USD -15.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 17K USD
Retained Earnings (Accumulated Deficit) -47.3M USD -24%
Stockholders' Equity Attributable to Parent 7.07M USD
Liabilities and Equity 10M USD +185%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.2M USD +18.6%
Net Cash Provided by (Used in) Financing Activities 5.42M USD +90233%
Net Cash Provided by (Used in) Investing Activities 2.03M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 24M shares +124%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.22M USD
Deferred Tax Assets, Valuation Allowance 12.7M USD +43.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Deferred Tax Assets, Gross 12.7M USD +43.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.39M USD -2.66%
Deferred Tax Assets, Operating Loss Carryforwards 8.87M USD +36.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares
Unrecognized Tax Benefits 646K USD +43.9%
Additional Paid in Capital 54.4M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 18K USD
Share-based Payment Arrangement, Expense 239K USD +67.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares